Abstract
Cardiac allograft vasculopathy (CAV) is a leading cause of mortality and re-transplantation late after heart transplantation (HT). Endothelin-1 (ET-1) has been implicated in the development of CAV, but has not been well-studied after HT. In 90 HT patients, plasma ET-1 was assayed within 8 weeks of
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
